Inflammatory markers in cystic fibrosis patients with transmissiblePseudomonas aeruginosa
Authors:
- A.M. JonesAJA.M. Jones
- L. MartinLML. Martin
- M.E. DoddMDM.E. Dodd
- A McDowellA McDowell
- K.L. MoffittKMK.L. Moffitt
- J.S. ElbornJEJ.S. Elborn
- A.K. WebbAWA.K. Webb
Open Access
- 1 September 2003
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 22 (3) , 503-506
Abstract
ChronicPseudomonas aeruginosainfection in cystic fibrosis (CF) leads to a damaging host inflammatory response. There are an increasing number of reports ofP. aeruginosacross-infection at CF centres. The clinical significance of acquisition of a transmissible strain for patients who already harbourP. aeruginosais unclear. In this study, levels of inflammatory markers in clinically stable adult CF patients who harbour transmissible and sporadic strains ofP. aeruginosahave been compared.Patients with CF and chronicP. aeruginosainfection were grouped into those who harbour a transmissibleP. aeruginosaand those who harbour their own sporadic strains. Total white cell and differential counts, sputum neutrophil elastase (NE), interleukin (IL)‐8, tumour necrosis factor (TNF)‐α, plasma IL‐6 and NE/α1‐antitrypsin complexes, serum C‐reactive protein, and urine TNF receptor 1 were all measured in clinically stable patients 4–6 weeks following completion of intravenous antibiotic therapy.The two groups (both n=20) were well matched for per cent predicted forced expiratory volume in one second, per cent predicted forced vital capacity and body mass index. There were no significant differences in levels of white cell counts or inflammatory markers between the two groups.At times of clinical stability, cystic fibrosis patients infected with transmissiblePseudomonas aeruginosado not have a heightened inflammatory response above that of those harbouring sporadic strains.Keywords
This publication has 27 references indexed in Scilit:
- Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosaThorax, 2002
- Cross infection of cystic fibrosis patients with Pseudomonas aeruginosaThorax, 2002
- Detection of a Widespread Clone of Pseudomonas aeruginosa in a Pediatric Cystic Fibrosis ClinicAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmasEuropean Respiratory Journal, 2001
- Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosisEuropean Journal of Clinical Investigation, 2000
- Determinants of Mortality from Cystic Fibrosis in Canada, 1970-1989American Journal of Epidemiology, 1996
- The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infectionRespiratory Medicine, 1993
- Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosisPediatric Pulmonology, 1992
- Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosaThe Journal of Pediatrics, 1990
- An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centreJournal of Antimicrobial Chemotherapy, 1986